Blog

Inflammatory Cytokine ELISA Kits | ExKits

Inflammatory cytokines represent a category of bioactive regulatory molecules that modulate multiple inflammatory responses in organisms, generally divided into two major subgroups: pro‑inflammatory cytokines and anti‑inflammatory cytokines. A dynamic balance maintained between these two subgroups is essential for sustaining normal immune homeostasis and facilitating physiological tissue repair after damage.

Pro‑inflammatory cytokines are predominantly secreted by Th1 lymphocytes, CD4‑positive immune cells, macrophages and dendritic cells. Their core biological function is to initiate and amplify systemic inflammatory cascades.

Commonly investigated pro‑inflammatory markers include IL‑1β, IL‑6, IL‑8, IL‑12, IL‑18, TNF‑α and IFN‑γ. Under pathological conditions such as pathogen infection, tissue trauma or cellular injury, these cytokines can activate immune cell populations, recruit inflammatory cells to lesion sites, and trigger targeted defensive responses against exogenous pathogens and tissue damage.

Anti‑inflammatory cytokines primarily function to suppress excessive inflammatory activation, balance immune reactions, and prevent sustained hyperinflammation that may lead to irreversible tissue injury and disease progression.

Key anti‑inflammatory members cover IL‑1 receptor antagonist (IL‑1ra), IL‑4 and IL‑10. Notably, several molecules including IFN‑α, TGF‑β, IL‑6 and IL‑11 exhibit dual regulatory properties; their pro‑or anti‑inflammatory performance varies depending on cell types and local microenvironmental conditions.

ExKits provides a comprehensive portfolio of high‑sensitivity and high‑performance ELISA kits targeting inflammatory cytokines. These research‑grade products are widely applied in exploring inflammatory mechanisms and immune response pathways.

Our reliable detection platforms support accurate quantitative measurement of cytokine expression levels, helping researchers clarify immune and inflammatory regulatory networks, and offering solid experimental evidence for drug development related to immune disorders and inflammatory diseases.